GlassScriptPhysician profile
William S Hudson
NPI 1922064914
$1,266.80
in general payments reported to CMS, 2019-2025
16 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $86.77 · 2021: $52.97 · 2022: $256 · 2023: $252 · 2024: $204 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.39 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $242.42 | 2019-2025 | Abilify Maintena, Rexulti, Nuedexta |
| Janssen Pharmaceuticals, INC | $166.71 | 2019-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $119.01 | 2021-2025 | Austedo Xr, Austedo Xr |
| Alkermes, INC. | $96.24 | 2022-2025 | Aristada, Lybalvi |
| Supernus Pharmaceuticals, INC. | $65.50 | 2022 | |
| Ironshore Pharmaceuticals INC. | $62.59 | 2023-2024 | Jornay Pm |
| Conmed Corporation | $60.37 | 2020 | |
| Axsome Therapeutics, INC. | $50.74 | 2023-2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $39.09 | 2023-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $24.46 | 2019 | |
| Corium, LLC | $20.76 | 2022 | |
| Avanir Pharmaceuticals, INC. | $18.21 | 2022 | |
| Allergan, INC. | $13.52 | 2020 | |
| Shire North American Group INC | $12.11 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.